181 related articles for article (PubMed ID: 24032529)
21. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
[TBL] [Abstract][Full Text] [Related]
22. 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats.
Villalón CM; Centurión D; del Mar Fernández M; Morán A; Sánchez-López A
Life Sci; 1999; 64(20):1839-47. PubMed ID: 10350358
[TBL] [Abstract][Full Text] [Related]
23. NaHS prejunctionally inhibits the cardioaccelerator sympathetic outflow in pithed rats.
Centurión D; de la Cruz SH; Castillo-Santiago SV; Becerril-Chacón ME; Torres-Pérez JA; Sánchez-López A
Eur J Pharmacol; 2018 Mar; 823():35-40. PubMed ID: 29378194
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
Scardochio T; Clarke PB
Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
[TBL] [Abstract][Full Text] [Related]
25. Divergent effects of D₂/₃ receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats.
Moreno M; Economidou D; Mar AC; López-Granero C; Caprioli D; Theobald DE; Fernando A; Newman AH; Robbins TW; Dalley JW
Psychopharmacology (Berl); 2013 Jul; 228(1):19-30. PubMed ID: 23407782
[TBL] [Abstract][Full Text] [Related]
26. Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats.
Lahlou S
Eur J Pharmacol; 1998 Jul; 353(2-3):227-37. PubMed ID: 9726652
[TBL] [Abstract][Full Text] [Related]
27. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939
[TBL] [Abstract][Full Text] [Related]
28. Modulation of intracellular calcium concentration by D2-like DA receptor agonists in non-peptidergic DRG neurons is mediated mainly by D4 receptor activation.
Segura-Chama P; Luis E; Almanza A; Pellicer F; Hernández-Cruz A; Mercado F
Neurosci Lett; 2020 Sep; 736():135267. PubMed ID: 32717335
[TBL] [Abstract][Full Text] [Related]
29. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
30. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
[TBL] [Abstract][Full Text] [Related]
31. Blockade of spinal dopamine D2 receptors enhances the pressor effect of intravenous quinpirole in normotensive, conscious rats.
Lahlou S
Pharmacol Toxicol; 2002 Feb; 90(2):94-9. PubMed ID: 12071432
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
33. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart.
Gómez Mde J; Rousseau G; Nadeau R; Berra R; Flores G; Suárez J
Can J Physiol Pharmacol; 2002 Jun; 80(6):578-87. PubMed ID: 12117307
[TBL] [Abstract][Full Text] [Related]
34. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
Collo G; Zanetti S; Missale C; Spano P
Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the dopamine D2 receptor agonist quinpirole with sympathetic vasomotor tone and the central action of rilmenidine in conscious rabbits.
van den Buuse M; Tritton SB; Burke SL; Head GA
J Auton Nerv Syst; 1998 Oct; 72(2-3):187-94. PubMed ID: 9851568
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
[TBL] [Abstract][Full Text] [Related]
37. Further characterization of the 5-HT1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT1B and 5-HT1D subtypes.
Sánchez-López A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):220-7. PubMed ID: 14673512
[TBL] [Abstract][Full Text] [Related]
38. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
Caine SB; Negus SS; Mello NK; Patel S; Bristow L; Kulagowski J; Vallone D; Saiardi A; Borrelli E
J Neurosci; 2002 Apr; 22(7):2977-88. PubMed ID: 11923462
[TBL] [Abstract][Full Text] [Related]
39. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.
Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Ruiz-Salinas I; González-Hernández A; Maassenvandenbrink A; Villalón CM
Eur J Pharmacol; 2013 Dec; 721(1-3):168-77. PubMed ID: 24076186
[TBL] [Abstract][Full Text] [Related]
40. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
